The average one-year price target for 908 Devices (NasdaqGM:MASS) has been revised to $10.20 / share. This is an increase of 33.33% from the prior estimate of $7.65 dated August 30, 2025.

The price target is an average of many targets provided by analysts. The latest targets range from a low of $8.08 to a high of $12.60 / share. The average price target represents an increase of 82.14% from the latest reported closing price of $5.60 / share.

What is the Fund Sentiment?

There are 220 funds or institutions reporting positions in 908 Devices. This is an increase of 21 owner(s) or 10.55% in the last quarter. Average portfolio weight of all funds dedicated to MASS is 0.08%, an increase of 66.02%. Total shares owned by institutions increased in the last three months by 11.26% to 30,186K shares. The put/call ratio of MASS is 0.25, indicating a bullish outlook.

What are Other Shareholders Doing?

AWM Investment holds 5,200K shares representing 14.41% ownership of the company. No change in the last quarter.

ARKG - ARK Genomic Revolution ETF holds 2,664K shares representing 7.38% ownership of the company. In its prior filing, the firm reported owning 2,707K shares , representing a decrease of 1.61%. The firm increased its portfolio allocation in MASS by 165.09% over the last quarter.

ARK Investment Management holds 2,648K shares representing 7.34% ownership of the company. In its prior filing, the firm reported owning 2,899K shares , representing a decrease of 9.48%. The firm increased its portfolio allocation in MASS by 6.48% over the last quarter.

KOMP - SPDR S&P Kensho New Economies Composite ETF holds 1,703K shares representing 4.72% ownership of the company. In its prior filing, the firm reported owning 217K shares , representing an increase of 87.24%. The firm increased its portfolio allocation in MASS by 494.95% over the last quarter.

CGOAX - Columbia Small Cap Growth Fund I holds 1,523K shares representing 4.22% ownership of the company. No change in the last quarter.